Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1909-1915, 2003; 10.1373/clinchem.2003.017756
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gay-Bellile, C.
Right arrow Articles by Le Bricon, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay-Bellile, C.
Right arrow Articles by Le Bricon, T.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:1909-1915.)
© 2003 American Association for Clinical Chemistry, Inc.


Automation and Analytical Techniques

Automated Multicapillary Electrophoresis for Analysis of Human Serum Proteins

Cécile Gay-Bellile1, Djaouida Bengoufa2, Pascal Houze1, Didier Le Carrer3, Mourad Benlakehal1, Bernard Bousquet1, Bernard Gourmel1 and Thierry Le Bricon1,a

1 Laboratoire de Biochimie A et de Neurobiologie and
2 Laboratoire d’Immunologie et d’Histocompatibilité, Hôpital St-Louis AP-HP, 1 avenue Claude Vellefaux, 75010 Paris, France.

3 Laboratoire de Biochimie Spécialisée, Hotel Dieu, 9 quai Moncousu, 44093 Nantes Cedex 1, France.

aAuthor for correspondence. Fax 33-1-4249-9247; e-mail thierry.le-bricon{at}sls.ap-hop-paris.fr.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: We evaluated a new, automated multicapillary zone electrophoresis (CE) instrument (Capillarys®, 4.51 software version; Sebia) for human serum protein analysis.

Methods: With the Capillarys ß1-ß2+® reagent set, proteins were separated at 7 kV for 4 min in 15.5 cm x 25 µm fused-silica capillaries (n = 8) at 35.5 °C in a pH 10 buffer with online detection at 200 nm. Serum samples with different electrophoretic patterns (n = 265) or potential interference (n = 69) were analyzed and compared with agarose gel electrophoresis (AGE; Hydrasys®-Hyrys®, Hydragel protein(e) 15/30® reagent set; Sebia).

Results: CVs were <3.5% for albumin, <11% for {alpha}1-globulin, <4.1% for {alpha}2-globulin, <7.4% for ß-globulin, and <5.8% for {gamma}-globulin (3 control levels); measured throughput was 60 samples/h. In patients without paraprotein (n = 116), the median differences between CE and AGE were -5.4 g/L for albumin, 4.0 g/L for {alpha}1-globulin, 0.7 g/L for {alpha}2-globulin, 0.6 g/L for ß-globulin (P <0.001 for all fractions), and -0.1 g/L for {gamma}-globulin (not significant). More samples had at least one {gamma}-migrating peak detected by CE (n = 135 vs 130; paraprotein detection limit, ~0.5–0.7 g/L), but fewer were quantified (n = 84 vs 91) because of {gamma}- to ß-migration shifts. There was a 1.2 g/L median difference between CE and AGE for {gamma}-migrating paraprotein quantification (n = 69; P <0.001). Several ultraviolet-absorbing substances (lipid emulsion, hemoglobin) or molecules (contrast agent, gelatin-based plasma substitute) induced CE artifacts.

Conclusions:The Capillarys instrument is a reliable CE system for serum protein analysis, combining advantages of full automation (ease of use, bar-code identification, computer-assisted correction of {alpha}1-globulins) with high analytical performances and throughput.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Analysis of serum proteins by electrophoresis is routinely used to screen and monitor not only B-cell malignancies (1)(2), but also immune and, to a lesser extent, inflammatory responses. In clinical chemistry laboratories, standard electrophoresis is usually performed using the agarose gel as a migration support (AGE). 1 Despite ready-to-use commercial reagent sets and semiautomated electrophoresis systems, this technique remains labor-intensive, with resulting limited analytical performances and throughput.

During the last decade, capillary electrophoresis (CE) has emerged as a powerful analytical tool (3)(4). High voltage applied in a thin (internal diameter <100 µm) fused-silica tube allows fast and efficient separation of ionized molecules or complexes (5). Protein analysis is usually performed in free solution with use of highly basic buffers to minimize interactions with capillary walls. Direct quantification is obtained in the low ultraviolet (UV) range (~200 nm via the peptide bonds) at the cathodic end of the capillary (6)(7). The first automated multicapillary instrument designed for routine serum protein analysis by CE, the Paragon CZE2000® (Beckman), was commercialized in 1994. Its advantages include high precision and resolution, slightly improved sensitivity for paraprotein detection (vs AGE), use of small amounts of sample and reagents, full automation, and high throughput (8)(9)(10)(11)(12)(13).

The aim of this study was to evaluate the performance of a recently launched automated multicapillary CE instrument (Capillarys®; Sebia) (14) for serum protein analysis. We compared the results with those obtained with our standard semiautomated AGE technique (Hydrasys®-Hyrys®; Sebia) (13).


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
electrophoresis
Capillary zone electrophoresis of serum proteins was realized on a Capillarys instrument (4.51 software version; Sebia). The process on the instrument is as follows: Serum specimens (up to 13 racks of 8 primary or secondary sample tubes) are 1:5 diluted with the migration buffer in dilution segments (40 µL of serum to a final volume of 200 µL). Samples are then hydrodynamically injected for 4 s by anodic depression (injected volume, ~1 nL). With the Capillarys ß1-ß2+® reagent set (Sebia), separation is obtained by applying a voltage of 7 kV for 4 min in eight fused-silica capillaries (total/effective length: 17.5/15.5 cm; i.d., 25 µm) in a pH 10 buffer at 35.5 °C controlled by Peltier effect. Online detection is at 200 nm in an optical cell (i.d., 100 µm) located at the cathodic end of the capillary and connected to the detector by eight optic fibers. In healthy individuals, six main protein fractions are detected in the following order: {gamma}-globulins, ß2-globulins, ßl-globulins, {alpha}2-globulins, {alpha}l-globulins, and albumin (Fig. 1 ); the electrophoretic mobilities of the predominant individual proteins are indicated (manufacturer’s data). Weekly cleaning of the capillaries by a washing solution (enzyme proteolytic surfactant, Capiclean®; Sebia) is recommended.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Capillarys electropherogram of serum proteins from a healthy individual.

The Capillarys automated instrument (ß1-ß2+ reagent set; Sebia) separates human serum proteins into six main fractions detected at the cathodic end of the capillary in the following order: {gamma}-globulins, ß2-globulins, ßl-globulins, {alpha}2-globulins, {alpha}l-globulins, and albumin. Electrophoretic mobilities of individual proteins were determined by immunosubtraction or overload, depending on the protein (manufacturer’s data). Serum samples may display qualitative variations in the {alpha}2- and/or {alpha}l-globulin fraction because of different phenotypes (e.g., for haptoglobin) and the presence of lipoproteins (manufacturer’s data). AAG, {alpha}1-acid glycoprotein; ATT, {alpha}1-antitrypsin; {alpha}2-M, {alpha}2-macroglobulin.

AGE of serum proteins was performed on a semiautomated Hydrasys system (Sebia) using the Hydragel protein(e) 15/30® reagent set (13). Briefly, after manual sample distribution (10 µL), separation is obtained in an 8 g/L agarose gel with the following automated steps: application for 30 s; separation in Tris-barbital buffer, pH 9.2, at a constant 20 W at 20 °C until 33 V-h have accumulated (~7 min), drying for 10 min at 65 °C, staining with amidoschwarz (4 g/L in an acidic solution), and destaining (0.5 g/L citric acid solution). Total analysis time is 45 min for 30 samples. Densitometric scanning of gels is performed at 570 nm (Hyrys densitometer; Sebia).

Quantitative results for each fraction of the CE or AGE electropherogram are expressed in g/L by multiplying the percentage of total area under the curve by total serum protein concentration.

analytical evaluation
Capillarys throughput was determined by analyzing 13 x 8 samples (all with bar codes) in a row. Carryover was assessed by alternating serum samples with distilled water (CDM Lavoisier; n = 30). The detection limit and precision studies were conducted according to the guidelines of the French Society of Clinical Biology (15), as follows: the detection limit was defined as 3 SD above the mean of 30 consecutive analyses of a blank (here distilled water), and for imprecision, CVs (within and between runs) were calculated based on 21 runs of at least two control specimens. A normal serum (both quantitatively and qualitatively), one with a low albumin concentration (26.9 g/L), and one containing a well-defined {gamma}-migrating paraprotein (27.7 g/L) were selected. Assay linearity was evaluated by gradually mixing 60 g/L solutions (in 9.0 g/L NaCl solution; Aguettant) of human albumin (Sigma) and {gamma}-globulins (Sigma) to obtain concentrations of 60, 50, 40, 30, 20, 10, and 5 g/L for each fraction (at a constant total protein concentration of 60 g/L). Sensitivity for paraprotein detection was checked by mixing samples containing either a cathodic {gamma}- (5.7 g/L) or anodic {gamma}-monoclonal (6.3 g/L) peak with a normal serum (15.0 g/L polyclonal {gamma}-globulins) down to the lowest peak concentration of 0.1 g/L; this was considered as the highest dilution giving a still discernible band.

We evaluated the effect of storage conditions, using a normal serum specimen kept at room temperature or 4 °C for 1, 8, 24, or 48 h and a lyophilized control (Sebia) stored for 1 week at 4 or 1 month at -20 °C.

specimens and interference study
A total of 432 blood samples obtained from hospitalized patients were grouped as follows. Group A (n = 265) contained carefully selected sera covering a wide range of electrophoretic patterns: within reference values (n = 25); single well-defined monoclonal immunoglobulin (n = 64; up to 93 g/L) or oligoclonal profiles/weak bands (n = 66); polyclonal hyper-{gamma}-globulinemia (15–85 g/L; n = 30), hypo-{gamma}-globulinemia (0.5–6.0 g/L; n = 30), hypoalbuminemia (10–30 g/L; n = 25), hyper-{alpha}l-globulinemia (>3 g/L) or hyper-{alpha}2-globulinemia (>9 g/L; n = 25). Group B (n = 98) contained unselected specimens from our daily routine that were analyzed blindly by AGE and CE. Group C (n = 69) contained samples with potential interference, including hemolysis (n = 19), lactescence (triglycerides >10 mmol/L; n = 7), icterus (total bilirubin >50 µmol/L; n = 20), increased C-reactive protein (CRP; >100 mg/L; n = 9), fibrinogen (sodium heparinate plasma; n = 5), and cryoglobulins (n = 9).

Blood was collected on a 7-mL tube without anticoagulant (Becton Dickinson) and centrifuged for 15 min at 1500g at 20 °C. Total serum protein was measured and AGE performed within 8 h before storage at -20 °C (groups A and C) or was analyzed immediately by CE (group B). Cryoglobulin samples were run on the Capillarys after 24 h of storage at 4 or 37 °C.

We evaluated the effects of UV-absorbing substances on the CE electropherogram by adding to 90 µL of a normal serum, 10 µL of a 70 g/L hemoglobin solution prepared from hemolysates (16), a sodium and meglumine ioxitalamate contrast agent (Telebrix®; Guerbet), or a lipid emulsion for parenteral nutrition (Ivelip® 10%; Baxter). We also evaluated the effect of a gelatin-based plasma substitute (Plasmion®; Roger Bellon) by mixing 50 µL of the solution with 50 µL of normal serum.

This study was conducted in accordance with the requirements of the Helsinki Declaration of 1975 as revised in 1996.

other biochemical markers
Total serum protein was determined by the Biuret reaction on a Modular® system (Roche). Bilirubin, triglyceride, and CRP concentrations were determined by standard biochemical methods using Roche reagent sets (Modular); hemoglobin was measured on a BN-100® nephelometer (Dade-Behring).

In case of discordant results between CE and AGE for group A patients, we performed serum immunofixation (IFE) using the Hydragel 4 IF® reagent set (Hydrasys; Sebia) with antibodies against IgG, IgA, IgM, and {kappa} and {lambda} light chains.

statistics
Statistical analysis was performed with Sigmastat®, Ver. 2.0 (Jandel Scientific). Results are expressed as the median and range or the mean and SD according to the population distribution (Kolmogorov–Smirnov test). Linear regression was used for analytical evaluation of CE linearity, and Deming regression analysis (17) was used for comparison of CE and AGE. Statistical significance was set at P <0.05 for all tests.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
analytical performances
Measured throughput was 60 samples/h with no sample carryover (median absorbance, 0.003, as for signal noise). In the precision study, maximum absorbance (median values) ranged from 0.1722 (low albumin control) to 0.2407 (paraprotein control) with CVs between 9.3% and 14% (between-run data). The results obtained for different protein fractions are presented in Table 1 . The assay was linear over a concentration range of 60–10 g/L for albumin (r = 0.99) and {gamma}-globulins (r = 0.98), with the detection limit (absorbance of 0.010) corresponding to ~3.5 g/L of a mixture containing 5 parts albumin and 1 part {gamma}-globulin. The detection limit was 0.5 g/L for the anodic {gamma}-migrating paraprotein and 0.7 g/L for the more cathodic {gamma}-migrating paraprotein. Storage conditions had no significant impact (both quantitative and qualitative) on the Capillarys electropherogram (data not shown).


View this table:
[in this window]
[in a new window]
 
Table 1. Result of precision study for the Capillarys, using three controls.1

method comparison study
The results of the method comparison for protein fraction quantification in the subgroup of group A patients without paraprotein (n = 116) are presented in Table 2 . Differences between methods were proportional to the protein fraction concentration for albumin (r = 0.52) and {alpha}1-globulins (r = 0.34; linear regression, P <0.001); we observed no significant difference between methods for {gamma}-globulins (Table 2 ). In the paraprotein subgroup, the following results were observed for {gamma}-migrating paraprotein quantification (n = 69): mean (SD) slope, 0.96 (0.04); mean (SD) intercept, 1.4 (0.2); r = 0.99; median difference, 1.2 g/L by CE (P <0.001). A Bland–Altman plot of individual differences is provided in Fig. 2 .


View this table:
[in this window]
[in a new window]
 
Table 2. Method comparison for protein fraction quantification in patients without paraprotein.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Bland–Altman analysis of paraprotein quantification by CE and AGE.

For paraproteins quantified by both CE and AGE (n = 69), the correlation between the two techniques was significant (r = 0.99). The median difference between CE and AGE was +1.2 g/L (P <0.001).

The total number of samples with at least one detectable abnormal peak in the {alpha}2 to the {gamma} zone was 135 by CE and 130 by AGE (Fig. 3 ). There was a 100% agreement in the subgroup of patients with a single well-defined paraprotein by AGE (n = 64). In others subgroups, additional peaks detected by CE corresponded to small or faint bands identified as monoclonal by IFE in 70% of cases. Fewer peaks could be quantified by CE than AGE because 15 of them (all quantified by AGE) were shifted from the {gamma} zone (by AGE) to the ß2 zone (identified as IgG in 58%, IgM in 34%, IgA in 8%; {kappa} in 58%, and {lambda} in 42%). Five patients with hypo-{gamma}-globulinemia by AGE had a small detectable peak by CE; only the three quantitatively most important peaks (0.7, 0.9, and 2.1 g/L) were detected and identified by IFE as oligoclonal, IgG{kappa}, and free {kappa} or IgD{kappa} or IgE{kappa}, respectively. In group B, results for {gamma}-globulins (CE/AGE; n = 98) were 62 and 71 normal, respectively; 17 and 15 with a single well-defined quantified peak; and 19 and 12, respectively, with a small peak or an oligoclonal profile.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Paraprotein detection and quantification by CE and AGE.

Selected sera (n = 265; group A) covering a wide range of electrophoretic patterns were analyzed by the Capillarys and AGE [Hydrasys-Hyrys; Hydragel protein(e) 15/30 reagent set; Sebia], including 130 samples with a single monoclonal immunoglobulin ({gamma}-migrating, n = 115; ß-migrating, n = 14; {alpha}2-migrating, n = 1) or an oligoclonal profile (two or more peaks by AGE).

in vivo (group c) and in vitro interferences
Hemolyzed serum samples had increased ß1-globulins and/or {alpha}2-globulins. Patients with a CRP <240 mg/L (n = 4) had no evident modification of the {gamma} zone of the electropherogram; a faint band in the anodic region of the {gamma}-globulins (close to fibrinogen) was observed in the two specimens with concentrations >300 mg/L. Icteric samples had no apparent modification of the CE electropherogram, whereas lipemic samples had increased {alpha}1-globulins with, in some cases, an additional peak close to albumin. After cryoglobulin storage at 4 °C, no peak was detected in the {gamma} zone of the Capillarys electropherogram in seven of nine samples. At 37 °C, a peak was detected in 100% of cases that corresponded to the measured cryoprecipitate (Table 3 ). Free hemoglobin, Telebrix, and Ivelip were responsible for the appearance of additional peaks in the ß1 zone (hemoglobin), at the junction of the {alpha}1-/{alpha}2-globulin zones (Telebrix), or in the {alpha}1-globulin zone (Ivelip). Addition of Plasmion increased the {gamma}-globulin fraction in a polyclonal-like way, a phenomenon confirmed in vivo in a patient treated with a similar product (Gélofusine®; B Braun Médical). Figures showing the interference of selected compounds (lipids, cryoglobulins, contrast agent, plasma substitute, and fibrinogen) are available as a Data Supplement accompanying the online version of this article athttp://www.clinchem.org/content/vol49/issue11/.


View this table:
[in this window]
[in a new window]
 
Table 3. Analysis of cryoglobulins by the Capillarys system after storage at 4 and 37 °C.1


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The Capillarys is the second generation of automated multicapillary instruments for serum protein analysis. Because it is fully automated (bar-code identification for patients and racks, preseparation steps, direct postseparation quantification), it requires almost no technical manipulation. The reproducibility of the Capillarys assay was excellent from sample preseparation steps (CV ~10% for sampling, dilution, and injection) to electrophoretic separation and quantification of protein fractions (CV, 1.2–7.1%), except for the flat, often large and heterogeneous {alpha}1-globulin zone (CV >10% with irreproducible integration). Similar results have been published with the Paragon CZE2000 (8)(9) and the earlier 4.41 version of the Capillarys (14). Despite good correlation with the Hydrasys-Hyrys for albumin and {gamma}-globulins (r = 0.99), there was an ~200% positive difference vs AGE for {alpha}1-globulins and a 15% negative difference for albumin. Reports in the literature indicate similar results for the Paragon CZE2000 (~100% difference for {alpha}1-globulins, but lower difference for albumin) (8)(9) and the Capillarys (14), highlighting the need for an adjustment of the protein fraction reference interval (9)(18). Comparisons with immunonephelometry and colorimetry suggest that quantification of albumin and {alpha}1-globulin in the low-UV range is more accurate than protein staining (8)(9), especially for {alpha}1-acid glycoprotein because of its high sialic acid content. Overall, the throughput for the Capillarys (~60 samples/h) was better than for AGE (~30 samples/h with the Hydrasys-Hyrys) (13) and the Paragon CZE2000 (~40 samples/h) (8).

The detection limits for paraproteins in the Capillarys were in the 0.5 g/L range, similar to the detection limits reported for the Paragon CZE2000 (8) and for the semiautomated Hydrasys-Hysis AGE system (13). Importantly, there were no well-defined single paraproteins missed by CE, as reported for a few cases with the earlier 4.41 buffer and software version of the Capillarys (14) or the Paragon CZE2000 (19)(20). In oligoclonal, hypo- and hyper-{gamma}-globulinemic subgroups, the Capillarys displayed higher sensitivity than AGE for the detection of weak monoclonal bands (70% of positivity by IFE), as has been observed with the Paragon CZE2000 (20). In 30% of discordant results with AGE (difficult and/or complex profiles of the {gamma}-globulins), however, abnormalities detected by CE were not confirmed by IFE, the gold standard method. They might correspond to other anodic {gamma}-proteins, such as small amounts of fibrinogen, CRP, or degraded products of the C3 complement (14). Because degradation of the C3 fraction of the complement is a temperature-dependent phenomenon (14), serum storage at 4 °C for 48 h or at -20 °C for more prolonged periods is recommended. Concerning paraprotein quantification, there was no gain in the number of peaks quantified by CE because of {gamma}- to ß2-migration shifts observed in 11.5% of paraproteins (mostly IgM or IgG). Importantly, however, the median difference with AGE was limited to 1.2 g/L with only five outliers (maximum difference, -9.0 g/L, or -17%), an improvement over previously published CE methods (9)(19).

Hemolysis, icterus, and turbidity (and associations of these) represent the most frequently encountered serum interferences in clinical chemistry. The electrophoretic mobility of hemoglobin in the Capillarys was similar to that reported with the Hydrasys-Hyrys (21), the Paragon CZE2000 (8)(9), and the earlier, 4.41 version of the Capillarys (14): {alpha}2-globulins (haptoglobin-hemoglobin complex) and ß-globulins for free hemoglobin. Icterus had no effect on the CE electropherogram (up to 300 µmol/L total bilirubin), but an increase in the baseline or, sometimes, a well-defined VLDL peak appeared between albumin and other {alpha}1-globulins proteins in hyperlipemic samples. An optional computer-assisted correction is available in the present 4.51 version, which deletes the area under the curve between albumin and {alpha}1-globulins. Use of this correction improved the automated integration of {alpha}1-globulins (~38% improvement of the analytical precision) and the correlation between CE and AGE [r = 0.90; slope = 1.29 (0.08); intercept = 1.2 (0.2)] and reduced the difference with AGE to +1.8 g/L (Fig. 4 ). After adjustment of reference values for {alpha}1-globulins, this correction could allow an easier screening of {alpha}1-antitrypsin deficiencies by CE (22). A computer-supported algorithm has also been developed by Beckman for the Paragon CZE2000 to recognize deficiency variants of {alpha}1-antitrypsin (23). Fibrinogen (heparinized samples or incompletely clotted serum) migrates in the anodic part of the {gamma}-globulins, close to C3. The high sensitivity of CE might also lead to the detection of endogenous proteins present in low concentrations (undetected by AGE), as observed in two specimens with a CRP >300 mg/L (faint band in the anodic {gamma}-globulin zone). The clinical incidence of this phenomenon might be limited because, in our experience, only ~0.5% of hospitalized patients have a serum CRP >300 mg/L, and it rarely exceeds 500 mg/L. Interestingly, controlling the temperature of the capillary at 35.5 °C also prevented cryoglobulins from precipitating during electrophoretic migration, thus allowing their detection and accurate quantification, an advantage over AGE.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 4. Correlation between CE and AGE for {alpha}1-globulins.

With the Capillarys ß1-ß2+ reagent set, VLDL migrates between albumin and {alpha}1-globulins, producing an increase in the baseline or, in some cases, an additional {alpha}1 peak. Computer-assisted correction of the {alpha}1 zone efficiently reduced the difference with quantification by AGE (median, 1.8 vs 4.0 g/L before correction) in the subgroup of patients without paraprotein (n = 116).

Overcoming interference by exogenous UV-absorbing substances is a new challenge in CE, not present in standard gel-based methods with indirect quantification by dye binding. As observed previously (14)(24), an iodinated radioopaque agent (Telebrix) was detected in the form of a {alpha}1-/{alpha}2-monoclonal-like peak, leading to a large converse error for all other fractions. During intravenous infusion of lipid emulsions (parenteral nutrition), the Capillarys algorithm should efficiently correct the {alpha}1-globulin zone. We also established that gelatin-based plasma substitutes falsely increase {gamma}-globulins in a polyclonal-like way. Visual inspection of serum specimens and knowledge of patient treatments are, therefore, of primary importance to avoid gross quantitative errors and misleading interpretations. Centrifugation (high speed or ultracentrifugation) for lipids or dialysis for small molecules might also help reduce interference. Considering the short half-lives of these drugs (e.g., 4 h for Gélofusine), performing CE of serum proteins at a distance from drug administration might be the safest alternative.

In conclusion, the Capillarys is an automated multicapillary zone electrophoresis instrument designed for human serum protein analysis. This high-throughput analytical system can save a substantial amount of technical time compared with AGE methods. Although not currently available (but available on the Paragon CZE2000), the most interesting perspective of the Capillarys is the immunologic identification of monoclonal proteins (25)(26)(27). Analysis of low-protein biological fluids (e.g., cerebrospinal fluid and urine) remains difficult (28)(29) because of the relative low sensitivity of UV detection and the presence of UV-absorbing interfering substances (especially in urine). More specialized analyses, such as for hemoglobin A1C (30) or transferrin sialoforms (31), have been successfully developed on research monocapillary electrophoresis systems, but are not currently available on multicapillary electrophoresis systems.


   Footnotes
 
1 Nonstandard abbreviations: AGE, agarose gel electrophoresis; CE, capillary electrophoresis; UV, ultraviolet; CRP, C-reactive protein; and IFE, immunofixation.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Attaelmannan M, Levinson SS. Understanding and identifying monoclonal gammopathies. Clin Chem 2000;46:1230-1238.[Abstract/Free Full Text]
  2. Keren DF, Warren JS, Lowe JB. Strategy to diagnose monoclonal gammopathies in serum: high resolution electrophoresis, immunofixation, and {kappa}/{lambda} quantitation. Clin Chem 1988;34:2196-2204.[Abstract/Free Full Text]
  3. Lehmann R, Voelter W, Liebich HM. Capillary electrophoresis in clinical chemistry. J Chromatogr B 1997;697:3-35.[CrossRef]
  4. Jenkins MA, Guerin MD. Capillary electrophoresis as a clinical tool. J Chromatogr B 1996;682:23-34.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  5. Lauer HH, McManigill D. Capillary zone electrophoresis of proteins in untreated fused silica tubing. Anal Chem 1986;58:166-169.[CrossRef]
  6. Chen FA. High-resolution protein analysis by automated capillary electrophoresis. Clin Chem 1992;38:1651-1653.[Free Full Text]
  7. Chen FA. Rapid protein analysis by capillary electrophoresis. J Chromatogr 1991;559:69-78.[CrossRef]
  8. Bienvenu J, Graziani MS, Arpin F, Bernon H, Blessum C, Marchetti C, et al. Multicenter evaluation of the Paragon CZE 2000® capillary zone electrophoresis system for serum protein electrophoresis and monoclonal component typing. Clin Chem 1998;44:599-605.[Abstract/Free Full Text]
  9. Bossuyt X, Schiettekatte G, Bogaerts A, Blanckaert N. Serum protein electrophoresis by CZE 2000 clinical capillary electrophoresis system. Clin Chem 1998;44:749-759.[Abstract/Free Full Text]
  10. Meunier JC. La détection et la caractérisation des composés monoclonaux difficiles dans le sérum: techniques sur gel ou électrophorèse capillaire. Ann Biol Clin 1999;57:605-610.
  11. Jaeggi-Groisman SE, Byland C, Gerber H. Improved sensitivity of capillary electrophoresis for detection of bisalbuminemia. Clin Chem 2000;46:882-883.[Free Full Text]
  12. Kalambokis G, Kitsanou M, Kalogera C, Kolios G, Seferiadis K, Tsianos E. Inherited bisalbuminemia with benign monoclonal gammopathy detected by capillary but not agarose gel electrophoresis. Clin Chem 2002;48:2076-2077.[Free Full Text]
  13. Godey F, Ropert M, Bouasria A, Lucas-Clerc C, Guenet L, Savoure N, et al. Le Paragon CZE 2000® et l’Hydrasys® pour l’électrophorèse des protéines sériques et le typage des immunoglobulines monoclonales sériques. Ann Biol Clin 1999;57:337-344.
  14. Bossuyt X, Lissoir B, Mariën G, Maisin D, Vunckx J, Blanckaert N, et al. Automated serum protein electrophoresis by Capillarys®. Clin Chem Lab Med 2003;41:704-710.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  15. Vassault A, Grafmeyer D, de Graeve J, Cohen R, Beaudonnet A, Bienvenu J. Analyses de biologie médicale: spécifications et normes d’acceptabilité à l’usage de la validation de techniques. Ann Biol Clin 1999;57:685-695.
  16. Jay DW, Provasek D. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 Assays. Clin Chem 1993;39:1804-1810.[Abstract]
  17. Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000;46:100-104.[Abstract/Free Full Text]
  18. Petrini C, Alessio MG, Scapellato L, Brambilla S, Franzini C. Serum proteins by capillary zone electrophoresis: approaches to the definition of reference values. Clin Chem Lab Med 1999;37:975-980.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  19. Jenkins MA, Kulinskaya E, Martin HD, Guerin MD. Evaluation of serum protein separation by capillary electrophoresis: prospective analysis of 1000 specimens. J Chromatogr B 1995;672:241-251.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  20. Henskens Y, De Winter J, Pekelharing M, Ponjee G. Detection and identification of monoclonal gammapathies by capillary electrophoresis. Clin Chem 1998;44:1184-1190.[Abstract/Free Full Text]
  21. Benlakehal M, Le Bricon T, Feugeas JP, Bousquet B. Influence de l’hémolyse sur le dosage et l’électrophorèse des protéines sériques. Ann Biol Clin 2000;58:367-371.
  22. Gonzales-Sagrado M, Lopez-Hernandez S, Martin-Gil FJ, Tasende J, Banuelos MC, Fernandez-Garcia N, et al. {alpha}1-Antitrypsin deficiencies masked by a clinical capillary electrophoresis system (CZE 2000). Clin Biochem 2000;33:79-80.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  23. Jonsson M, Carlson J. Computer-supported interpretation of protein profiles after capillary electrophoresis. Clin Chem 2002;48:1084-1093.[Abstract/Free Full Text]
  24. Arranz-Pena ML, Gonzalez-Sagrado M, Olmos-Linares AM, Fernandez-Garcia N, Martin-Gil FJ. Interference of iodinated contrast media in serum capillary zone electrophoresis. Clin Chem 2000;46:736-737.[Free Full Text]
  25. Bossuyt X, Bogaerts A, Schiettekatte G, Blanckaert N. Detection and classification of paraproteins by capillary immunofixation/subtraction. Clin Chem 1998;44:760-764.[Abstract/Free Full Text]
  26. Litwin CM, Anderson SK, Philipps G, Martins TB, Jaskowski TD, Hill HR. Comparison of capillary zone and immunosubstraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies. Am J Clin Pathol 1999;112:411-417.[ISI][Medline] [Order article via Infotrieve]
  27. Jonsson M, Carlson J, Jeppson JO, Simonsson P. Computer-supported detection of M-components and evaluation of immunoglobulins after capillary electrophoresis. Clin Chem 2001;47:110-117.[Abstract/Free Full Text]
  28. Kolios G, Bairaktari E, Tsolas O, Seferiadis K. Routine differential diagnosis of proteinurias by capillary electrophoresis. Clin Chem Lab Med 2001;39:784-788.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  29. Sanders E, Katzmann JA, Clark R, Oda RP, Shihabi Z, Landers J. Development of capillary electrophoresis as an alternative to high resolution agarose electrophoresis for the diagnosis of multiple sclerosis. Clin Chem Lab Med 1998;37:37-45.[CrossRef]
  30. Doelman CJA, Siebelder CWM, Nijhof WA, Weykamp CW, Janssens J, Penders TJ. Capillary electrophoresis system for hemoglobin A1c determinations evaluated. Clin Chem 1997;43:644-648.[Abstract/Free Full Text]
  31. Giordano BC, Muza M, Trout A, Landers JP. Dynamically-coated capillaries allow for capillary electrophoretic resolution of transferrin sialoforms via direct analysis of human serum. J Chromatogr B 2000;742:79-89.



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
X. Bossuyt and G. Marien
Detection of Monoclonal Proteins by Capillary Zone Electrophoresis: Comparison of 2 Multichannel Automated Systems
Clin. Chem., January 1, 2007; 53(1): 152 - 153.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Vermeersch, G. Marien, and X. Bossuyt
A Case of Pseudoparaproteinemia on Capillary Zone Electrophoresis Caused by Geloplasma
Clin. Chem., December 1, 2006; 52(12): 2309 - 2311.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Luraschi, I. Infusino, I. Zorzoli, G. Merlini, C. Fundaro and, and C. Franzini
Heavy Chain Disease Can Be Detected by Capillary Zone Electrophoresis
Clin. Chem., January 1, 2005; 51(1): 247 - 249.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Gijbels, J. De Coster, and X. Bossuyt
Interference by Gelatin-Based Plasma Substitutes in Capillary Zone Electrophoresis
Clin. Chem., August 1, 2004; 50(8): 1473 - 1475.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gay-Bellile, C.
Right arrow Articles by Le Bricon, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay-Bellile, C.
Right arrow Articles by Le Bricon, T.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS